PTP4A1 and metastatic malignant neoplasm in the lymph nodes: It is suggested that advanced stages of TNM and lymph node metastasis will increase the peripheral blood CTC count and hinder the expression of PTP4A1, thereby affecting the prognosis of patients with esophageal cancer.